Cargando…
Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study
PURPOSE: Extracorporeal membrane oxygenation (ECMO) has become an established therapy for severe respiratory failure in coronavirus disease 2019 (COVID-19). The added benefit of receiving ECMO in COVID-19 remains uncertain. The aim of this study is to analyse the impact of receiving ECMO at speciali...
Autores principales: | Whebell, Stephen, Zhang, Joe, Lewis, Rebecca, Berry, Michael, Ledot, Stephane, Retter, Andrew, Camporota, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892395/ https://www.ncbi.nlm.nih.gov/pubmed/35238946 http://dx.doi.org/10.1007/s00134-022-06645-w |
Ejemplares similares
-
Correction to: Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study
por: Whebell, Stephen, et al.
Publicado: (2022) -
The need to define “who” rather than “if” for ECMO in COVID-19
por: Whebell, Stephen, et al.
Publicado: (2022) -
Phenotypes of severe COVID-19 ARDS receiving extracorporeal membrane oxygenation
por: Zhang, Joe, et al.
Publicado: (2021) -
Physiological Basis of Extracorporeal Membrane Oxygenation and Extracorporeal Carbon Dioxide Removal in Respiratory Failure
por: Ficial, Barbara, et al.
Publicado: (2021) -
Restrictive Transfusion Practice in Adults Receiving Venovenous Extracorporeal Membrane Oxygenation: A Single-Center Experience
por: Doyle, Andrew J., et al.
Publicado: (2020)